Zerbaxa
Brand Name: Zerbaxa
Generic Name: Ceftolozane (as sulfate) + Tazobactam (as sodium)
Active
Registration Number
DR-XY45714
Dosage Form
Powder for Injection (I.V. Infusion)
Issuance Date
February 16, 2023
Expiry Date
December 19, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength1 g/500 mg
Packaging20 mL-capacity USP Type I clear and colorless glass vial ealed with bromobutyl rubber stopper and aluminum seal with purple plastic flip-off cap (Box of 10's)
Classification
C
Classification
Prescription Drug (RX)
A
Application
Initial (from Monitored Release)
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
Ceftolozane (as sulfate)Active
Monograph: ceftolozane (as sulfate)
Tazobactam (as sodium)Active
Monograph: Meropenem/Tazobactam